Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Moore v TPL

My audit of TPL has documented MMP revenue of $260M. My 25% would be $65M. Deducting $25M for SEAForth expenses leaves $40M of which I've been paid $10M. So $30M is unaccounted for. I conclude that TPL owes me at least $20M of which he admits to $6M


Our investment in PDS for the fiscal year ended May 31, 2008 provided income after expenses in the amount of approximately $19,926,000 as compared to income after expenses in the amount of approximately $48,965,000 for the fiscal year ended May 31, 2007

Our investment in the joint venture provided net income after expenses in the amount of approximately $27,848,000 for the fiscal year ended May 31, 2006.

PTSC total net license revenues, $96,739,000

50% of above(as an approximation of Moore's 25%), $48,369,000

PTSC's revenues include the $10,000,000 Intel one-time payment, which may impact on the calculation.


Might it be that a simple error has occurred in basing net receipts on gross income?

Tax would be a further deduction.

Or is there a $30,000,000 shortfall, as stated?




Be well

Share
New Message
Please login to post a reply